Cancer is closely related to aging in that the incidence of cancer increases exponentially with age. The molecular commonality between human embryonic stem cells (hESCs) and cancer cells suggests a strong linkage between hESCs and cancer cells[@b1],[@b2]. Thus, to a certain extent, cancer is a developmental disease. In fact, the initiation, proliferation, and metastasis of cancer are often associated with abnormalities in various developmental signatures. An in-depth investigation of the molecular mechanisms that connect aging, stem cells, and cancer could provide meaningful insights into the biology of cancer. The emergence of a huge amount of "omics" data provides a platform for the investigation of the related mechanisms through a computational biology approach. In particular, microarray-based gene expression data that are related to aging, stem cells, and cancer are valuable resources whereby molecular associations among aging, stem cells, and cancer could be discovered.

Molecular Associations Between Aging and Cancer {#s2}
===============================================

To date, only one study has investigated the association between aging and cancer by an extensive examination of the expression profiling of aging-related genes in various human tumor types[@b3].

Identification of human aging-related genes {#s2a}
-------------------------------------------

I have identified 3,359 human aging-related genes on the basis of 10 relevant publications; these genes are involved in the aging of six different tissues: the brain, eye, kidney, muscle, skin, and blood[@b3]--[@b13]. From these 3,359 genes, I identified 69 aging-related signature genes (ASGs) that are commonly expressed in multiple tissues. The functional analysis of the 69-gene set revealed two important KEGG pathways: pathways in cancer and MAPK signaling pathway, both of which are significantly relevant to cancer. The gene ontology (GO) analysis of the 69 genes identified significant aging-related GO terms, including oxidative stress, mitochondrial function, apoptosis and senescence, and DNA damage repair. These GO terms are also strongly implicated in cancer. In addition, I obtained 261 human aging-related genes (HAGs) from the Human Ageing Genomic Resources website (<http://genomics.senescence.info/genes/allgenes.php>)[@b14], which is an important resource that collects HAGs. Within this 261-gene list, certain genes play important roles in both aging and cancer. For example, FOS regulates cell proliferation, differentiation, apoptosis, and transformation, and has been associated with aging and cancer[@b15]. FOXO1 belongs to the forkhead family of transcription factors, which are strongly associated with human longevity[@b16] and cancer [@b17]. TP63 encodes a member of the P53 family of transcription factors and has been associated with aging and cancer-related pathology[@b18],[@b19].

Expression profiling of human aging-related genes in tumors {#s2b}
-----------------------------------------------------------

I have identified 28 sets of differentially expressed genes by the 28 normal vs. tumor phenotypes class comparisons in 25 human tumor gene expression datasets; subsequently, I analyzed the overlap between each of these 28 gene sets and each of the aforementioned ASGs and HAGs[@b3]. [Table 1](#cjc-32-04-155-t01){ref-type="table"} presents several representative genes that are highly overlapping between both classes of datasets, which include not only the aforementioned FOS, FOXO1, and TP63 but also certain other genes, such as APOD[@b20], IGF1[@b21] and FOXM1[@b22] that have also been shown to strongly correlate aging with cancer. Gene function enrichment analyses suggested that these highly overlapping genes were primarily involved in metabolic process, cell cycle regulation, DNA damage response, apoptosis, cell proliferation, and transcriptional regulation. Based on these highly overlapping genes, I have identified several convergent pathways between aging and cancer. These pathways include pathways in cancer, ErbB signaling pathway, MAPK signaling pathway, cell cycle, T-cell receptor signaling pathway, mTOR signaling pathway, B-cell receptor signaling pathway, p53 signaling pathway, insulin signaling pathway, VEGF signaling pathway, and chemokine signaling pathway, among others.

###### Genes commonly identified in aging-related and tumor-related gene sets

  Gene set    Total number of genes   The number of genes with 5 or more overlaps   The number of genes with a 50% or greater overlapping rate                                                            Highly overlapping representative genes
  ---------- ----------------------- --------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------
  ASG                  69                              69 (100%)                                                17                                          PGK1, FN1, YWHAZ, AHNAK, NEBL, VCAN, ABI2, PRKCB, WNK1, FGF1, GATM, SFPQ, HPGD, PTGER3, COX7C, LAMP1, H2AFV, APOD, FOXO1, TP63, FOS
  HAG                  261                             234 (90%)                                                33                               CLU, JUND, APP, MAPT, NR3C1, PML, YWHAZ, TCF3, TOP2A, VEGFA, APOE, PRKCA, CDKN2A, HOXB7, IGFBP3, PTK2, SHC1, TERF1, ATP5O, CCNA2, FGFR1, FOXM1, IGF1, TP53

AGS, aging-related signature genes; HAG, human aging-related genes.

Molecular Associations Between Stem Cells and Cancer {#s3}
====================================================

Identification of human stem cell-related molecular signatures {#s3a}
--------------------------------------------------------------

Based on a literature mining approach[@b1], I have identified four types of hESC-related molecular signatures: genes, pathways, transcription factors (TFs), and microRNAs (miRNAs). The gene signatures include 24 hESC-related gene sets involving the targets of three core TFs (OCT4, SOX2, and NANOG) in hESCs, the targets of Oncogene c-Myc, the targets of the tumor suppressor p53, and the targets of polycomb group proteins; these gene sets are essential for controlling the development of hESCs. The pathway signatures include 54 hESC-related pathways that essentially belong to developmental signaling pathways such as the Wnt, Notch, Hedgehog, and Bmi-1 pathways that are necessary for the regulation of stem cell self-renewal and differentiation. The TF signatures include 189 hESC-related TFs that are primarily involved in the regulation of hESC self-renewal and differentiation. Among these TFs, OCT4, SOX2, and NANOG have essential roles in the transcriptional control of the regulatory circuitry underlying pluripotency[@b23],[@b24]. The miRNA signatures include 114 hESC-related miRNAs that have important roles in regulating stem cell self-renewal and differentiation[@b25].

![Overlapping rate between human embryonic stem cell (hESC)-related gene sets and differentially expressed gene sets.\
Each number represents the proportion of genes in the corresponding hESC-related gene set that have no less than 10 occurrences in the 72 differentially expressed gene sets identified in tumors.](cjc-32-04-155-g001){#cjc-32-04-155-g001}

Expression profiling of human stem cell-related molecular signatures in tumors {#s3b}
------------------------------------------------------------------------------

I have analyzed 51 human gene expression datasets involving 23 tumor types and identified differentially expressed genes among either normal vs. tumor or good prognosis vs. poor prognosis phenotype classes[@b1]. Furthermore, I identified important tumor-related pathways, TFs, and miRNAs by analyzing gene sets for differential expression among these pre-defined classes.

I have identified 72 sets of differentially expressed genes in the 51 cancer-related human gene expression datasets and found considerable overlaps between each of the 72 cancer-related gene sets and each of the 24 hESC-related gene sets[@b1]. [Figure 1](#cjc-32-04-155-g001){ref-type="fig"} presents the proportion of genes in each of the 24 hESC-related gene sets that have no less than 10 occurrences in the 72 cancer-related gene sets and demonstrates that a substantial portion of the hESC-related genes are also related to cancer. The highly overlapping genes are mainly involved in cell cycle regulation, DNA damage repair and replication, apoptosis, development and differentiation, cell adhesion, and TF activity.

I have identified 68 groups of pathways by 75 class comparisons and survival analyses of the cancer-related datasets and found that 26 hESC-related pathway signatures appeared in at least 8 groups[@b1]. [Figure 2](#cjc-32-04-155-g002){ref-type="fig"} presents the occurrence rate of each of the 26 pathways in the 68 groups of cancer-related pathways. Among the highly overlapping pathways between hESCs and cancer, the cell cycle pathway and MAPK pathway are most prominent. The IGF, ERK, SHH, WNT, PRC2, Notch, PTEN, and TGFβ pathways are also important signaling pathways that link hESCs to cancer.

I have identified 73 groups of TFs in the human cancer gene expression datasets[@b1]. Among the 189 hESC-associated TFs, 42 TFs appeared in at least 3 groups. [Figure 3](#cjc-32-04-155-g003){ref-type="fig"} presents the occurrence rate of each of the 42 TFs in the 73 groups of cancer-related TFs. The most frequently identified hESC-related TF in tumor was MYC. In fact, MYC is an important TF in both hESCs and cancer cells[@b23],[@b26]--[@b35], and its regulatory networks may account for most of the transcriptional similarity between embryonic stem cells (ESCs) and cancer cells[@b33]. Several families of hESC-associated TFs, such as MYB, E2F, PAX, SMAD, STAT, POU, SP, and GLI, were shown to be related to cancer ([Figure 3](#cjc-32-04-155-g003){ref-type="fig"}).

I have identified 67 groups of miRNAs in the cancer datasets [@b1]. Among the 114 hESC-associated miRNAs, 50 miRNAs appeared in at least 20 different groups. The most frequently identified miRNA was miR-29c, which occurred 34 times (51 % occurrence rate), and the next most common miRNA was miR-200b, which occurred 30 times (45% occurrence rate). [Figure 4](#cjc-32-04-155-g004){ref-type="fig"} lists the 50 miRNAs for which the occurrence frequency is no less than 20, indicating that there is a broad range of overlap between "sternness" miRNAs and oncogenic miRNAs. Certain miRNA families, such as the miR-302 family and the miR-200 family, appear to play an important role in the regulation of hESCs and tumorigenesis[@b36]--[@b42].

![Overlapping rate between hESC-related pathways and differentially expressed pathways.\
Each number represents the occurrence rate of the corresponding hESC-related pathway in the 68 cancer-related pathway sets.](cjc-32-04-155-g002){#cjc-32-04-155-g002}

![Overlapping rate between hESC-related transcription factors (TFs) and differentially expressed TFs.\
Each number represents the occurrence rate of the corresponding hESC-related TF in the 68 cancer-related TF sets.](cjc-32-04-155-g003){#cjc-32-04-155-g003}

![Overlapping rate between hESC-related microRNAs and differentially expressed microRNAs.\
Each number represents the occurrence rate of the corresponding hESC-related microRNA in the 67 cancer-related microRNA sets.](cjc-32-04-155-g004){#cjc-32-04-155-g004}

Other works identifying common molecular signatures between cancer and stem cells {#s3c}
---------------------------------------------------------------------------------

In addition to the previously discussed work[@b1], several other studies have examined the expression of hESC-associated genes in human cancer[@b2],[@b29],[@b30],[@b43],[@b44]. For instance, Murat *et al*.[@b43] provided the first clinical evidence for the existence of a "glioma stem cell" or "self-renewal" phenotype in the context of the treatment resistance of glioblastoma. Santagata *et al.*[@b44] explored the expression levels of the ESC TFs OCT3/4, NANOG, and SOX2 in primary and metastatic germ cell tumors (GCTs). They confirmed NANOG and OCT3/4 as sensitive and specific markers for primary seminoma and embryonal carcinoma and demonstrated that NANOG was a marker for metastatic GCTs. Their findings showed that ESC TFs were useful in the diagnosis of tumors that were metastatic to the retroperitoneum. Ben-Porath *et al*.[@b2] identified a subset of hESC-associated transcriptional regulators, including Nanog, Oct4, Sox2, and c-Myc, that were highly expressed in poorly differentiated tumors. They found a novel link between genes associated with hESC identity and the histopathologic traits of tumors and suggested that these genes might contribute to the stem cell-like phenotypes presented by many tumors. Hassan *et al.*[@b29] used microarray gene expression analysis to identify gene set enrichment patterns between human lung adenocarcinoma and squamous cell carcinoma. This analysis revealed that an increased expression of the ESC gene set and decreased expression of the Polycomb target gene set identified poorly differentiated lung adenocarcinoma and that this gene expression signature was associated with markers of poor prognosis and worse overall survival in lung adenocarcinoma. Schoenhals *et al*.[@b30] compared the expression levels of the pluripotency factors OCT4, SOX2, KLF4, and MYC in 40 human tumor types with the levels in the normal tissue counterparts using publicly available gene expression data and found significant overexpression of at least one of these factors in 18 out of the 40 investigated cancer types. Furthermore, they found that these genes were associated with tumor progression or poor prognosis. Overall, these studies revealed that "sternness" gene expression signatures were associated with tumor malignancies and therefore might be informative molecular predictors for cancer therapy outcomes[@b45].

Discussion {#s4}
==========

Cancer is related to aging. Many aging-related genes demonstrate differential expression profiling between normal tissues and tumor. Two significant aging-related pathways, pathways in cancer and MAPK signaling pathway, are also implicated in Carcinogenesis. Certain critical molecular mechanisms underlie both aging and cancer; these mechanisms include cell cycle regulation, metabolic process, DNA damage response, apoptosis, p53 signaling pathway, immune/inflammatory response, etc. It is worthy of note that the immune/inflammatory response is an important link between aging and cancer, given that the convergent pathways between aging and cancer include multiple pathways that correlate with the immune/inflammatory response, such as T-cell receptor signaling pathway, mTOR signaling pathway, B-cell receptor signaling pathway, and chemokine signaling pathway (see Table 5 of reference [@b3]).

Cancer is also related to development. Various hESC-specific characteristics, including genes, pathways, TFs, and miRNAs, were often differentially expressed between normal and tumor phenotypes or among cancer subtypes with distinct clinical outcomes. The signaling pathways like the cell cycle, MAPK, SHH, WNT, PRC2, Notch, PTEN, and TGFβ pathways, that played an important role in control of the hESC fate were also strongly implicated in the initiation, proliferation, and metastasis of cancer. The hESC-specific TFs like OCT4 and c-Myc were important in the maintenance of the undifferentiated state of cancer cells. The miRNAs that were overexpressed in undifferentiated hESCs like miRNA-302 and miRNA-200 families were also involved in cancerous pathology. The mechanism of cell cycle regulation provides the primary commonality between hESCs and cancer cells in that the hESC-associated signatures most frequently identified in tumors are primarily involved in the regulation of cell cycle[@b1].

The huge amount of available "omics" data facilitates the investigation of the associations among aging, stem cells, and cancer using the computational biology approach. This approach constitutes an important supplement to the traditional experimental approach. However, the findings obtained through the computational biology approach are only reliable after they have been experimentally validated.

With the development of next-generation sequencing (NGS) technology, increasing quantities of cancer-related sequencing data are emerging. In contrast to microarray methods, NGS can directly determine the cDNA sequences and quantify the expression of diverse RNA molecules from genomes over a wide range of levels[@b46]. RNA sequencing (RNA-Seq) is useful for studying complex transcriptomes and revealing sequence variations, such as SNPs, in the transcribed regions[@b47]. RNA-Seq has a large dynamic range of expression levels over which transcripts can be detected and is therefore highly accurate for quantifying expression levels. Moreover, this approach also has high levels of reproducibility and requires less RNA samples. The bioinformatics investigation of NGS data will provide a promising direction for cancer informatics research.
